NYSE : STVN
Stevanato Group S.p.A. — Key statistics
Healthcare · Medical Instruments & Supplies · Italy
Last price 20.24 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.53B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.29B |
| Enterprise Value | 5.71B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jun 11, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 49.83M |
| Shares Outstanding | 273.13M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 17.59% |
| Float | 49.04M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 34.62 |
| Forward PE | 25.95 |
| PS Ratio | 3.78 |
| Forward PS | 3.61 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 19.08 |
| PEG Ratio | 1.60 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 37.14 |
| EV / Sales | 4.08 |
| EV / EBITDA | 16.73 |
| EV / EBIT | 23.09 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.61 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.46 |
| Debt / FCF | n/a |
| Interest Coverage | 37.25 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.13% |
| Return on Assets (ROA) | 5.45% |
| Return on Invested Capital (ROIC) | 8.01% |
| Return on Capital Employed (ROCE) | 10.61% |
| Weighted Average Cost of Capital (WACC) | 7.86% |
| Revenue Per Employee | $232,908 |
| Profits Per Employee | $25,588 |
| Employee Count | 6,010 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.97 |
Taxes
| Measure | Value |
|---|
| Income Tax | 65.86M |
| Effective Tax Rate | 29.99% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -24.88% |
| 50-Day Moving Average | 20.58 |
| 200-Day Moving Average | 18.10 |
| Relative Strength Index (RSI) | 44.86 |
| Average Volume (20 Days) | 385,521 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 965,956 |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 0.35% |
| Short % of Float | 1.97% |
| Short Ratio (days to cover) | 3.04 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.40B |
| Gross Profit | 411.53M |
| Operating Income | 247.40M |
| Pretax Income | 219.63M |
| Net Income | 153.78M |
| EBITDA | 341.40M |
| EBIT | 247.40M |
| Earnings Per Share (EPS) | $0.56 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 90.42M |
| Total Debt | 508.74M |
| Net Cash | -418.33M |
| Net Cash Per Share | -$1.53 |
| Equity (Book Value) | 1.77B |
| Book Value Per Share | 6.48 |
| Working Capital | 404.98M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 277.43M |
| Capital Expenditures | -289.68M |
| Depreciation & Amortization | 91.80M |
| Net Borrowing | 27.38M |
| Free Cash Flow | -12.25M |
| FCF Per Share | -$0.04 |
Margins
| Measure | Value |
|---|
| Gross Margin | 29.40% |
| Operating Margin | 17.67% |
| Pretax Margin | 15.69% |
| Profit Margin | 10.99% |
| EBITDA Margin | 24.39% |
| EBIT Margin | 17.67% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.06 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | 1.13% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 11.15% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.28% |
| Earnings Yield | 2.89% |
| FCF Yield | -0.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $24.84 |
| Price Target Difference | 28.17% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 8.42% |
| EPS Growth Forecast (3Y) | 15.56% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.14 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |